Aperio Group’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Aperio Group’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,988	Closed	-$210K	–	2460
2020 Q3	$210K	Sell	3,988 -1,232	-24%	-$76K	﹤0.01%	2206
2020 Q2	$320K	Buy	5,220 +1,219	+30%	+$70.5K	﹤0.01%	1999
2020 Q1	$226K	Sell	4,001 -930	-19%	-$53K	﹤0.01%	2047
2019 Q4	$280K	Buy	+4,931	New	+$261K	﹤0.01%	2093
2019 Q3	–	Sell	-4,496	Closed	-$269K	–	2952
2019 Q2	$269K	Buy	4,496 +571	+15%	+$35.9K	﹤0.01%	2064
2019 Q1	$245K	Sell	3,925 -10	-0.3%	-$661	﹤0.01%	2089
2018 Q4	$239K	Buy	+3,935	New	+$235K	﹤0.01%	2055

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Aperio Group's BSTC Position: Q4 2020 in Review

Aperio Group sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 3,988 shares — an estimated $210K sold.

Aperio Group first reported a position in BSTC in Q4 2018 and held it in 7 quarters. The position peaked at $320K in Q2 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Aperio Group reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Aperio Group sold 3,988 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $210K.
Aperio Group first reported a position in BioSpecifics Technologies Corp. in Q4 2018 and held it in 7 quarters.
Aperio Group's BioSpecifics Technologies Corp. position peaked at $320K in Q2 2020.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.